ROBINSON JAMES GEORGE purchased 0.3% of their position (8.50K shares) of NYMOX PHARMACEUTICAL CORP on the open market
Open‑market purchase worth $15.0K — a small addition. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 5/31/2019ACC: 0001651844-19-000004
Director
Since Oct 2018
+8.50K
Net shares
Net buyer
$15.0K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
8.50K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+100.00
Price / share
$1.76
Trade value
$176.50
% of position
0.0%
5/30/2019
3.34M→3.34M
Common Stock
Direct
Shares
+600.00
Price / share
$1.77
Trade value
$1.06K
% of position
0.0%
5/30/2019
3.34M→3.34M
Common Stock
Direct
Shares
+100.00
Price / share
$1.77
Trade value
$176.75
% of position
0.0%
5/30/2019
3.34M→3.34M
Common Stock
Direct
Shares
+7.70K
Price / share
$1.76
Trade value
$13.55K
% of position
0.2%
5/30/2019
3.34M→3.34M
Total
Net shares
+8.50K
Net value
$14.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/30/2019 | P · Purchase | +100.00 | $1.76 | $176.50 | 0.0% | 3.34M | 3.34M |
| Common Stock Direct | 5/30/2019 | P · Purchase | +600.00 | $1.77 | $1.06K | 0.0% | 3.34M | 3.34M |
| Common Stock Direct | 5/30/2019 | P · Purchase | +100.00 | $1.77 | $176.75 | 0.0% | 3.34M | 3.34M |
| Common Stock Direct | 5/30/2019 | P · Purchase | +7.70K | $1.76 | $13.55K | 0.2% | 3.34M | 3.34M |
| Total | +8.50K | $14.97K | ||||||
Derivative Transactions0
No derivative transactions reported